Chengdu Olymvax Biopharmaceuticals Inc. Price (688319.SS)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

405,440,226

(0.0432)%

Chengdu Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Olymvax Biopharmaceuticals Inc. develops and supplies vaccines. The company offers vaccines for Tetanus, a deadly infectious disease that causes nervous system toxicity by toxigenic clostridium tetanus; and haemophilus influenzae type b. it also develops vaccines for Staphylococcus aureus, a pathogenic bacterium that causes hospital infection and community infection; and Group A streptococcus disease. The company was founded in 2009 and is based in Chengdu, China. Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $7.06-16.15
  • Market Cap 6.03B
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Biotechnology

  • ceo: Mr. Shaowen Fan
  • IPO Date: June, 08, 2021
  • Country: CN
  • Currency: CNY
  • Headquaters: No Data
  • Employees: 471

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation